NOS3 and endothelial dysfunction: In vitro infusion with tetrahydrobiopterin (BH4), a cofactor for endothelial nitric oxide synthase (eNOS) activity, reverted endothelial dysfunction, favoring nitric oxide (NO) production and reduction of oxidative stress in the microvasculature (Franco Mdo et al., 2004).